Prognostic significance of lymphovascular invasion in radical prostatectomy specimens

BJU International

Volumn 108, Issue 4, 2011, Pages 502-507

  Yee, David S ^a   Shariat, Shahrokh F ^a   Lowrance, William T ^a   Maschino, Alexandra C ^a   Savage, Caroline J ^a   Cronin, Angel M ^a   Scardino, Peter T ^a   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

disease progression; lymphovascular invasion; prostate; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHOVASCULAR INVASION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SEMINAL VESICLE; SEMINAL VESICLE INVASION; TUMOR CELL;

HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; VASCULAR NEOPLASMS;

EID: 79961042041     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09848.x     Document Type: Review

References (30)

1. Diblasio CJ, Kattan MW,. Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 2003; 62 (Suppl. 1): 9-18 (Pubitemid 41116559)
2. Srigley JR, Amin MB, Epstein JI, et al,. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med 2006; 130: 936-46 (Pubitemid 44061419)
3. Kikuchi E, Margulis V, Karakiewicz PI, et al,. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-8
4. Shariat SF, Svatek RS, Tilki D, et al,. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 1402-12
5. Lotan Y, Gupta A, Shariat SF, et al,. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23: 6533-9 (Pubitemid 46190245)
6. Babaian RJ, Troncoso P, Bhadkamkar VA, et al,. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 2001; 91: 1414-22 (Pubitemid 32319250)
7. Bahnson RR, Dresner SM, Gooding W, et al,. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989; 15: 149-55 (Pubitemid 19262143)
8. Cheng L, Jones TD, Lin H, et al,. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 2005; 174: 2181-5 (Pubitemid 41611770)
9. De la Taille A, Rubin MA, Buttyan R, et al,. Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients? Eur Urol 2000; 38: 79-84 (Pubitemid 30418020)
10. Epstein JI, Partin AW, Potter SR, et al,. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000; 56: 283-8 (Pubitemid 30495584)
11. Ferrari MK, McNeal JE, Malhotra SM, et al,. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Urology 2004; 64: 749-53 (Pubitemid 39446056)
12. Herman CM, Wilcox GE, Kattan MW, et al,. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol 2000; 24: 859-63 (Pubitemid 30366274)
13. Ito K, Nakashima J, Mukai M, et al,. Prognostic implication of microvascular invasion in biochemical failure in patients treated with radical prostatectomy. Urol Int 2003; 70: 297-302 (Pubitemid 36566261)
14. Loeb S, Roehl KA, Yu X, et al,. Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression. Urology 2006; 68: 99-103 (Pubitemid 44037752)
15. May M, Kaufmann O, Hammerman F, et al,. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU Int 2007; 99: 539-44 (Pubitemid 46238825)
16. McNeal JE, Yemoto CE,. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am J Surg Pathol 1996; 20: 1351-60 (Pubitemid 26367206)
17. Salomao DR, Graham SD, Bostwick DG,. Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 1995; 119: 1050-4 (Pubitemid 26063813)
18. Shariat SF, Khoddami SM, Saboorian H, et al,. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 2004; 171: 1122-7 (Pubitemid 38327540)
19. Van den Ouden D, Kranse R, Hop WC, et al,. Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma. Urol Int 1998; 60: 17-24 (Pubitemid 28072434)
20. Yamamoto S, Kawakami S, Yonese J, et al,. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer. Int J Urol 2008; 10: 895-9
21. Kattan MW, Wheeler TM, Scardino PT,. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499-507 (Pubitemid 29220858)
22. Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87 (Pubitemid 26072233)
23. Stephenson AJ, Scardino PT, Eastham JA, et al,. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005; 23: 7005-12
24. Bostwick DG, Grignon DJ, Hammond ME, et al,. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 995-1000 (Pubitemid 30602040)
25. Sesterhenn IA, Weiss RB, Mostofi FK, et al,. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 1992; 10: 69-78
26. Lapham RL, Grignon D, Ro JY,. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 1997; 14: 109-22 (Pubitemid 27233149)
27. Larsen MP, Steinberg GD, Brendler CB, et al,. Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and 'pseudovascular' invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 1990; 3: 83-8
28. Miyata Y, Kanda S, Ohba K, et al,. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 2006; 176: 348-53 (Pubitemid 43815391)
29. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-6 (Pubitemid 36109741)
30. Roma AA, Magi-Galluzzi C, Kral MA, et al,. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate carcinoma. Mod Pathol 2006; 19: 392-8 (Pubitemid 43276993)